(Q38074456)

28 August 2017

1 reference

title

The Combined Assessment of Function and Survival (CAFS): a new endpoint for ALS clinical trials (English)

1 reference

amyotrophic lateral sclerosis

28 August 2017

1 reference

based on heuristic

inferred from title

author

Leonard H van den Berg

5

object named as

Leonard H van den Berg

1 reference

28 August 2017

4

Merit E Cudkowicz

1 reference

28 August 2017

James D Berry

1

1 reference

28 August 2017

Robert Miller

2

1 reference

28 August 2017

Dan H Moore

3

1 reference

28 August 2017

Douglas A Kerr

6

1 reference

28 August 2017

Yingwen Dong

7

1 reference

28 August 2017

Evan W Ingersoll

8

1 reference

28 August 2017

Donald Archibald

9

1 reference

28 August 2017

17 January 2013

1 reference

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

28 August 2017

1 reference

28 August 2017

14

1 reference

28 August 2017

3

1 reference

28 August 2017

162-168

1 reference

Designing clinical trials in amyotrophic lateral sclerosis

28 August 2017

1 reference

https://api.crossref.org/works/10.3109%2F21678421.2012.762930

New considerations in the design of clinical trials for amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21678421.2012.762930

Defining survival as an outcome measure in amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21678421.2012.762930

The ALSFRSr predicts survival time in an ALS clinic population.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21678421.2012.762930

Current clinical trials in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21678421.2012.762930

Methodologic discussions for using and interpreting composite endpoints are limited, but still identify major concerns

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21678421.2012.762930

Procedures for comparing samples with multiple endpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21678421.2012.762930

Composite outcomes in cardiovascular research: a survey of randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21678421.2012.762930

Joint modelling of longitudinal measurements and event time data.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21678421.2012.762930

An approach to joint analysis of longitudinal measurements and competing risks failure time data

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21678421.2012.762930

The effects of dexpramipexole (KNS-760704) in individuals with amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21678421.2012.762930

Comparison of analysis approaches for phase III clinical trials in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21678421.2012.762930

Shared parameter models for the joint analysis of longitudinal data and event times

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21678421.2012.762930

Dexpramipexole effects on functional decline and survival in subjects with amyotrophic lateral sclerosis in a Phase II study: Subgroup analysis of demographic and clinical characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21678421.2012.762930

10.3109/21678421.2012.762930

21 January 2018

Identifiers

DOI

1 reference

28 August 2017

1 reference